Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter: A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME Study.

The Journal of urology·2026
Same author

Sperm DNA fragmentation and its association with semen parameters in male infertility: A cross-sectional study.

Urologia·2025
Same author

On training networks of monostable multivibrator timer neurons.

Neural networks : the official journal of the International Neural Network Society·2025
Same author

ECG features improve multimodal deep learning prediction of incident T2DM in a Middle Eastern cohort.

Scientific reports·2025
Same author

A Fingertip-Mimicking 1216 200 m-Resolution e-Skin Taxel Readout Chip With Per-Taxel Spiking Readout and Embedded Receptive Field Processing.

IEEE transactions on biomedical circuits and systems·2024
Same author

Urothelial carcinoma in COVID-19: lessons from a pandemic and their impact on clinical practice.

Future oncology (London, England)·2021

Related Experiment Video

Updated: Jul 4, 2026

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

14.4K

Erectile Dysfunction in Young Adults: A Narrative Review.

Ali Safa1,2, Chady Waked3

  • 1Urology, Hôtel-Dieu de France, Beirut, LBN.

Cureus
|August 14, 2025
PubMed
Summary

Erectile dysfunction (ED) is rising in young men, affecting up to 35% and stemming from psychological and organic causes. Comprehensive management involves lifestyle changes, therapy, and medication.

Keywords:
erectile dysfunctionmale sexual healthorganic erectile dysfunctionpsychogenic erectile dysfunctionyoung adult male

More Related Videos

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.5K
Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model
05:48

Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model

Published on: September 20, 2021

1.7K

Related Experiment Videos

Last Updated: Jul 4, 2026

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

14.4K
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.5K
Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model
05:48

Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model

Published on: September 20, 2021

1.7K

Area of Science:

  • Urology
  • Andrology
  • Men's Health

Background:

  • Erectile dysfunction (ED) is increasingly diagnosed in men under 40.
  • Historically, ED was considered a condition primarily affecting older men.
  • Psychogenic factors were once thought to be the main cause of ED in younger populations.

Purpose of the Study:

  • To review the epidemiology of ED in young men.
  • To explore the psychosocial impact and etiological factors of ED in this demographic.
  • To synthesize current management strategies for ED in young males.

Main Methods:

  • A narrative review of scientific literature was performed.
  • PubMed's search builder was utilized with keywords "Erectile Dysfunction" and "Young."
  • 1,981 articles were identified, with selection based on relevance and quality.

Main Results:

  • Prevalence rates of ED in young men range up to 35%.
  • Causes include psychogenic factors (anxiety, depression) and organic issues (endothelial dysfunction, hormonal imbalances, metabolic syndrome).
  • Lifestyle factors like pornography use, poor sleep, diet, inactivity, and drug use are linked to ED.

Conclusions:

  • ED in young men is a complex, prevalent condition requiring thorough evaluation.
  • Management necessitates a multidisciplinary approach, combining pharmacologic and non-pharmacologic interventions.
  • Further research is needed to enhance treatment outcomes for this growing patient group.